Biotechnology News

March 31, 2014

TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) has announced an agreement with Eisai Inc. (Eisai), a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen® and to an enzyme inhibitor...

March 31, 2014

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine (STO:AERO-B) With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by a new share issue in...

March 31, 2014

BURTON-ON-TRENT, England--(BUSINESS WIRE)--Clinigen Group plc (‘Clinigen’ or the ‘Group’) (LSE: CLIN) (AIM: CLIN) the specialty global pharmaceutical company today announces the acquisition of SAVENE® (dexrazoxane) from SpePharm AG, a majority...

March 31, 2014

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--e-Therapeutics reports positive interim results from UK phase Ia. ETS2101 well tolerated with no serious adverse events. Early evidence of possible halting of tumour progression.

March 31, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment...

March 28, 2014

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Announces Increase to Previously Announced Financing

March 28, 2014

CAMBRIDGE, Mass. CAMBRIDGE, Mass.--(BUSINESS WIRE)--FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart

March 28, 2014

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of products and services to the global health science market, announced that it has entered into a definitive agreement (the "Arrangement Agreement") to be...

March 28, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY). The Daily Mirror, a British newspaper, recently reported the tragic story of a father who lost both legs, an arm and half of his face to deadly flesh-eating...

March 28, 2014

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular announces patent protecting the use of Lipoparticles for antibody discovery.

March 28, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) (“the Company” or “RegeneRx”) today announced that it received the initial $1.35 million payment pursuant to its product license and securities purchase agreement with...

March 28, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Comprehend will be leading sessions at two key industry events in April – Partnerships in Clinical Trials and Clinical Operations in Oncology Trials West Coast Conference.

March 28, 2014

BEVERLY, Mass.--(BUSINESS WIRE)--North Shore InnoVentures, one of New England’s leading technology incubators, announced today that it has received a capital grant of $1.65 million from the Massachusetts Life Sciences Center.

March 28, 2014

SEATTLE--(BUSINESS WIRE)--BEAT BioTherapeutics Corporation (BEATBio) announced today that co-founder and Scientific Advisory Board member, Dr. Michael Regnier, will present at the upcoming American College of Cardiology Annual Scientific Sessions...

March 28, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for...

March 28, 2014

LONDON--(BUSINESS WIRE)--PSE & Pfizer announce the formation of the Systems-based Pharmaceutics Alliance (SbP Alliance).

March 28, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced positive top-line data from its randomized, double-blind, placebo controlled Phase 2 trial of IMO-8400 in 32 patients with moderate-to-severe plaque...

March 28, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

March 28, 2014

TAINAN, Taiwan--(BUSINESS WIRE)--The partnership between National Cheng Kung University (NCKU), southern Taiwan, and Delta Electronics, the nation's biggest supplier of power supply units, has been hailed as the most successful industry-academia...

March 28, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): The Nomination Committee of Meda AB proposes the election of Guido Oelkers and Martin Svalstedt as new board members and proposes the appointment of Martin Svalstedt as...

March 28, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: On April 1, 2014, Precise Biometrics AB (STO:PREC) will publish a convening notice for the Annual General Meeting in Post- och Inrikes Tidningar and on the company’s web page. An advertisement that...

March 27, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is supporting the Annual Tour de Cure in Australia through its sponsorship, fund raising efforts, and donation of...

March 27, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Marketing Authorisation Application (MAA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the...

March 27, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna announce fourth quarter and full year 2013 financial results.

March 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that the U.S. Food and Drug Administration’s (FDA) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee determined by a unanimous vote...

March 27, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Bordetella pertussis (B. pertussis), its fifth assay on the...

March 27, 2014

WASHINGTON--(BUSINESS WIRE)--BIO, the NSF, and the NIH today announced an agreement to feature SBIR/STTR funded early-stage biotech companies in a newly-created Innovation Zone at the 2014 BIO International Convention.

March 27, 2014

SAN DIEGO--(BUSINESS WIRE)--Nature Genetics Founding Editor Kevin Davies Joins Pathway Genomics’ Scientific Advisory Board

March 27, 2014

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter has announced significant progress in its solution for state-of-the-art product packaging, designed to support the prevention of product counterfeiting. This innovative development is in response to...

March 27, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter and year ended December 31, 2013. Revenues for the year ended December 31, 2013 were $30.8 million compared to $21.6...

March 27, 2014

HOUSTON--(BUSINESS WIRE)--CompanionDx Reference Lab (www.companiondxlab.com), a high-complexity CLIA-certified laboratory specializing in pharmacogenomics, cancer...

March 27, 2014

WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) announced that Kay Holcombe will be joining staff as Senior Vice President, Science Policy. “We are very fortunate to have Kay join the BIO team,” said Jim...

March 27, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex confirms Takeda will present additional data from the Examine Trial at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

PARIS--(BUSINESS WIRE)--Privately held Arterial Remodeling Technologies (‘ART’) announced today that it has signed a structured buyout agreement with Terumo Corporation. Under the agreement, ART and Terumo Corporation will collaborate in the...

March 27, 2014

DENVER--(BUSINESS WIRE)--An outbreak of the deadly Ebola virus in West Africa has prompted Corgenix Medical to extend its existing Lassa viral hemorrhagic fever rapid test development to include the Ebola virus.

March 27, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the year ended December 31, 2013. “2013 was a productive and eventful year for Retrophin,” said Martin Shkreli, Founder and Chief Executive Officer...

March 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Hosted by the BioPharmaceutical Technology Center Institute (BTC Institute) and Promega Corporation, the 13th Annual International Bioethics Forum will take place May 1–2, 2014, in Madison, Wisconsin.

March 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Expanding on its mission to put patients at the center of clinical research, PatientsLikeMe says that patients can now apply to lead the development of new health outcome measures on its ORE platform

March 27, 2014

NEW YORK--(BUSINESS WIRE)--SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on NanoViricides, Inc. (NYSE-MKT:NNVC), a...

March 27, 2014

SAN ANTONIO--(BUSINESS WIRE)--Mobile healthcare leader achieves another first: mobilizing waveform data from non-invasive sensors operating outside hospital walls for high-risk pregnancies.

March 27, 2014

DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriTeQ rebrands its Q Inside SmartMarker radiation dose measurement product, which is FDA cleared to measure radiation dose at the site of a breast tumor or prostate tumor.

March 27, 2014

PRINCETON, N.J., & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the results of a pre-specified subanalysis of the Phase 3 ARISTOTLE trial that assessed the effect of blood...

March 27, 2014

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics Submits Request for Face to Face Meeting with FDA; Receives Notification on PMA Extension for LuViva® Advanced Cervical Scan